The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Children, pregnant women executed, tortured in North Korea: report

  • 3

    INTERVIEWForeign-born entertainers seek to revolutionize local industry

  • 5

    College students turn to 1,000 won breakfast to beat inflation

  • 7

    Rare Joseon-era map returns home from Japan

  • 9

    Celebrity chef Paik Jong-won takes his business skills to next level with 'The Genius Paik'

  • 11

    Carmakers unveil latest models at Seoul Mobility Show

  • 13

    Seventeen to drop new EP next month

  • 15

    Chun Doo-hwan's grandson to visit May 18 National Cemetery

  • 17

    Donald Trump indicted; 1st ex-president charged with crime

  • 19

    Law denying fathers birth registration of extramarital children ruled unconstitutional

  • 2

    IU says she was excited to share screen with Park Seo-joon in 'Dream'

  • 4

    Korea to scrap customs form for travelers without dutiable goods

  • 6

    NewJeans, Apple join hands to bring immersive audio experience

  • 8

    Korean aesthetics, spirit live on at Gyeongbok Palace

  • 10

    South Korea nominates new ambassador to US

  • 12

    Japanese top visitors to Korea in 2023 as tourism rebounds

  • 14

    INTERVIEWSouth Korea needs to make decision on sending lethal aid to Ukraine : CNAS CEO

  • 16

    Hyundai, BMW and Ford to recall over 12,000 vehicles over faulty parts

  • 18

    Gwangju's popular Alleyway restaurant resurrects

  • 20

    4 candidates nominated for Woori Bank CEO post

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Sat, April 1, 2023 | 01:12
Celltrion to launch COVID-19 treatment soon
Posted : 2020-12-29 16:43
Updated : 2020-12-30 09:15
Nam Hyun-woo
Print PreviewPrint Preview
Font Size UpFont Size Up
Font Size DownFont Size Down
  • facebook
  • twitter
  • kakaolink
  • whatsapp
  • reddit
  • mailto
  • link
Celltrion's COVID-19 treatment CT-P59 / Courtesy of Celltrion
Celltrion's COVID-19 treatment CT-P59 / Courtesy of Celltrion

By Nam Hyun-woo

Celltrion is expected to launch its COVID-19 treatment as early as next month, raising hopes that it will be able to combat the new coronavirus strain which is causing fear due to its high transmissibility.

The company said it has applied for conditional approval for its CT-P59 treatment from the Ministry of Food and Drug Safety. Conditional approval is given to a new drug that has finished Phase 2 clinical trials, if there is no other treatment for the disease. The drug developer is required to continue with and finish full clinical trials at the same time.

Hours after receiving Celltrion's application, the ministry said it has begun its review.

Earlier this week, the ministry said it will shorten the review period for drugs to treat COVID-19 from 180 days to 40 days. Given this, the treatment is anticipated to become available in late January.

The Phase 2 trials were conducted on 327 patients in Korea, Romania, Spain and the U.S., and final treatment injections took place Nov. 25. Celltrion said it decided to apply for domestic approval immediately after the trials, because "the company believes it has secured enough evidence and data to file for approval."

Since the trials were designed in coordination with the ministry, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency, the company is expecting the emergency approval processes to proceed smoothly in those regions. The company plans to apply for emergency use authorization in the U.S. and Europe next month, and will launch contiguous Phase 3 clinical trials in 10 countries soon.

If Celltrion's treatment gets domestic approval, it will be the world's third company to develop a COVID-19 treatment from scratch, following Eli Lilly and Regeneron.

In a conference held Monday, Celltrion Vice Chairman Kee Woo-sung said CT-P59 is designed for the early treatment of mild COVID-19 cases, and the company has confirmed that the drug is effective against all variants of the coronavirus.

The fear over new COVID-19 strains is growing in Korea. The Central Disease Control Headquarters has confirmed that a mutated coronavirus strain that's been spreading in the U.K. infected three Koreans who entered Korea, Dec. 23.

Overseas news outlets are reporting that the variant could be up to 70 percent more infectious than others already in circulation. Though the government said Tuesday there is "slim chance of the U.K. variant circulating in the country," public fear is growing as the U.K. and other variants are spreading rapidly across the globe.

Following Celltrion's announcement, the company's share price rose, closing at 360,500 won, Tuesday, up 10.8 percent from the previous session.

As conditional approval is expected, Celltrion sent text messages to its employees and executives Sunday asking for them to stop trading any shares they held in the company and its two listed affiliates.

"Due to our development of a COVID-19 treatment, public attention is high on employees' and executives' trading of company shares," the message read. "Until the treatment gets approval, employees and their family members are asked not to trade listed Celltrion Group shares."

The message, however, came after eight executives and their family members sold more than 30,000 Celltrion shares. Of them, Celltrion Holdings Vice Chairman Yoo Heon-young sold 10,000 shares, worth about 3.6 billion won, followed by Executive Director Baek Kyung-min who sold 7,078 shares worth 2.5 billion won.


Emailnamhw@koreatimes.co.kr Article ListMore articles by this reporter
 
Top 10 Stories
1Gwangju's popular Alleyway restaurant resurrectsGwangju's popular Alleyway restaurant resurrects
2[INTERVIEW] North Korean defectors bear brunt of remittance scams INTERVIEWNorth Korean defectors bear brunt of remittance scams
3Chun Woo-won apologizes to Gwangju victims, calls grandfather 'criminal' Chun Woo-won apologizes to Gwangju victims, calls grandfather 'criminal'
4Koreans warned against making inappropriate videos in ThailandKoreans warned against making inappropriate videos in Thailand
5Ambassador offers taste of Ghana to Korea Ambassador offers taste of Ghana to Korea
6Korea ready to greet BIE inspection team Korea ready to greet BIE inspection team
7Gimpo airport to launch care service for dogs Gimpo airport to launch care service for dogs
8Yoon gov't disputes Japanese media's claims about summit Yoon gov't disputes Japanese media's claims about summit
9Mirae Asset, SK Telecom team up for security token businessMirae Asset, SK Telecom team up for security token business
10Regulators urge financial groups to minimize interest rate hikesRegulators urge financial groups to minimize interest rate hikes
Top 5 Entertainment News
1IU says she was excited to share screen with Park Seo-joon in 'Dream' IU says she was excited to share screen with Park Seo-joon in 'Dream'
2[INTERVIEW] Foreign-born entertainers seek to revolutionize local industry INTERVIEWForeign-born entertainers seek to revolutionize local industry
3NewJeans, Apple join hands to bring immersive audio experience NewJeans, Apple join hands to bring immersive audio experience
4Celebrity chef Paik Jong-won takes his business skills to next level with 'The Genius Paik' Celebrity chef Paik Jong-won takes his business skills to next level with 'The Genius Paik'
5Seoul Museum of Art to open Korea's first public art archive Seoul Museum of Art to open Korea's first public art archive
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group